This study does not refer to ethical approval and consent to participate. The data used in this study was obtained from gene databases.
1. Prediction of disease targets
<ol>
	<li>Access the GeneCards database (https://www.genecards.org) and online Mendelian inheritance in man database (OMIM, https://www.omim.org), utilizing &#34;anus eczema&#34; as the search term for disease targets.</li>
	<li>Download the spreadsheets of the disease targets. Delete the repeated targets to obtain the anus eczema targets.</li>
</ol>
2. Selection of active components
<ol>
	<li>Search the keyword &#34;indigo naturalis, golden cypress, calcined gypsum, calamine, and Chinese Gall&#34; on the Traditional Chinese Medicine system&#39;s pharmacology database (TCMSP;&#160;http://tcmspw.com/tcmsp.php) to obtain the list of the candidate active ingredients and targets of SDG.</li>
	<li>Entrust the component onto the Swiss ADME database (http://www.swissadme.ch/index.php), extracting details of those exhibiting &#34;high&#34; GI absorption, coupled with at least two &#34;Yes&#34; DL values as active elements. 
	NOTE: Normally, only ingredients with drug-like (DL) values &#8805;0.18 in the database are included as active ingredients.</li>
</ol>
3. Construction of the PPI network and screening of the core proteins
<ol>
	<li>In Venny2.1( https://bioinfogp.cnb.csic.es/tools/venny/index.html), enter the targets of SDG and anus eczema into LIST1 and LIST2, respectively. A visual representation of the intersection is generated instantly. Click on the shared area to reveal the common targets in the&#160;Results section.</li>
	<li>Access the STRING database (https://string-db.org/). Enter the targets in the&#160;List of Names field. Then Select Homo sapiens as the Organism and proceed with Search &#62; Continue.</li>
	<li>When the results are available, open Advanced Settings and select the hide disconnected nodes in the network. In the Minimum Required Interaction Score, set the highest confidence (0.900) and then click on Update.</li>
	<li>Click on Exports to download the text of the protein-protein interaction (PPI) network in .png and .tsv format.</li>
</ol>
4. Construction of a drug-component-disease-target network
<ol>
	<li>Open Cytoscape 3.9.1 and import the .tsv file mentioned in step 3.4. Click on the Style bar in the control panel to optimize the color, font, and side of the network nodes.</li>
	<li>For network topology analysis, employ the Analyze Network function. To obtain hub genes, use CytoHubba in Cytoscape software. Establish the drug-component-disease-target network.</li>
</ol>
5. GO and KEGG enrichment analysis
<ol>
	<li>Access the Metascape website (https://metascape.org/). Select a file or paste a gene list into the dialog box and click the&#160;Submit button. Then select H. sapiens in both Input as Species and Analysis as Species; after that, enable the Custom Analysis function.</li>
	<li>In the enrichment option, select GO Molecular Functions, GO Biological Processes, GO Cellular Components, and the KEGG Pathway database. Check Pick Selective GO Clusters, then click on the Enrichment Analysis button. Upon completion of the progress bar, initiate an Analysis Report Page click to retrieve the enrichment results.</li>
</ol>
6. GEO gene chip dataset analysis
<ol>
	<li>Search and analyze the GEO gene chip dataset (GDS3806) using the GEO2R tool (https://ncbi.nlm.nih.gov/geo/geo2r/) to investigate the expression of central genes in different data groups (control group-non-atopic dermatitis; experimental group-atopic dermatitis).</li>
	<li>Enter the GEO database website (https://www.ncbi.nlm.nih.gov/geo/). Input keyword or GEO Accession, and click on the&#160;Search button. Select the best matching result. Find the Reference Series (GSE26952).</li>
	<li>Enter the GEO2R tool website (https://ncbi.nlm.nih.gov/geo/geo2r/), enter the reference series in the&#160;GEO Accession box, and click the Set button. Select Atopic Dermatitis as the experimental group, select Nonatopic Control as the control group, and click the Analyze button. After the calculation is completed, the result will appear.</li>
</ol>
7. Molecular docking
<ol>
	<li>Open the TCMSP database and download the 3D structure of the selected ingredients. Use the Chemical Name search box and search the selected ingredient names to download the corresponding 3D structure files in mol2 format.</li>
	<li>Open the RCSB protein database (http://www.pdb.org/) and download the crystal structures of the key targets. In the search box, search the target names and download the corresponding crystal structure files in pdb format.</li>
	<li>Import ingredients and target structure files into the analysis software. Delete water molecules by clicking on Edit &#62; Delete Water. Add hydrogens by clicking on Edit &#62; Hydrogens &#62; Add. Set the ingredients as the ligand, select whole targets as the receptor, and perform blind docking.</li>
	<li>Determine the range of molecular docking.
	<ol>
		<li>Select the receptor and ligand in sequence. Click on Grid &#62; Grid Box to adjust the grid box to include the entire model. Click on File &#62; Close saving current to save the grid box status. Save files in gpf format.</li>
		<li>Click on Run &#62; Run Autogrid4 &#62; Parameter Filename &#62; Browse, select the gpf file, then click the Launch button.</li>
	</ol>
	</li>
	<li>Use AutoDock 4 to perform molecular docking.
	<ol>
		<li>Click on Docking &#62; Macromolecule &#62; Set Rigid Filename to select the receptor. Click on Docking &#62; Ligand &#62; Open/ Choose to select the ligand.</li>
		<li>Click on Docking &#62; Search Parameters to set operation algorithms and Docking &#62; Docking Parameters to set docking parameters. Select the dpf file, then click the Launch button. Save files in the dpf format.</li>
		<li>Click on Analyze &#62; Docking &#62; Open, select the dlg file, click on Analyze &#62; Macromolecule to open the receptor, click on Analyze &#62; Conformations &#62; Play, Ranked by Energy to analyze the results. Click Set Play &#62; Write Complex to save the results in pdbqt format.</li>
	</ol>
	</li>
	<li>Import the docking files into PyMOL software to construct further visualization.
	<ol>
		<li>Select the ligand, and click on Action &#62; Find &#62; Polar Contacts &#62; To Other Atoms in Object to display hydrogen bonds between ligands and the external environment. Click on c to change color.</li>
		<li>Click on Action &#62; Extract Object. Click on Show &#62; Sticks to show the stick structure of the receptor. Identify the residues connected to ligands and show the stick structure.</li>
		<li>Click on Hide &#62; Sticks to hide the stick structure of the receptor. Click on Wizard &#62; Measurement and click on two atoms in sequence. Click on Label &#62; Residue to show the label of the residues. Adjust the background color and transparency if necessary. Click on File &#62; Export Image as to save the picture.</li>
	</ol>
	</li>
</ol>

Network Pharmacology and GEO Dataset Analysis of SDG in Anus Eczema Treatment

<ol>
	<li>Ma, M., Lu, H., Yang, Z., Chen, L., Li, Y., Zhang, X. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Differences+in+microbiota+between+acute+and+chronic+perianal+eczema.">Differences in microbiota between acute and chronic perianal eczema.</a> Medicine. 100 (16), e25623 (2021).</li><li>Dietrich, C. F., Hoch, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Anal+eczema.">Anal eczema.</a> Revue Therapeutique. 78 (9), 509-512 (2021).</li><li>Dietrich, A., Ruzicka, T., Hermans, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Differential+diagnosis+of+anal+eczema.">Differential diagnosis of anal eczema.</a> Hautarzt. 66 (6), 400-407 (2015).</li><li>Rohde, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Anal+eczema,+condylomata+acuminata.">Anal eczema, condylomata acuminata.</a> Deutsche Medizinische Wochenschrift. 133 (6), 245-246 (2008).</li><li>Havlickova, B., Weyandt, G. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Therapeutic+management+of+anal+eczema:+an+evidence-based+review.">Therapeutic management of anal eczema: an evidence-based review.</a> International Journal of Clinical Practice. 68 (11), 1388-1399 (2014).</li><li>Rainer, B. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Characterization+and+analysis+of+the+skin+microbiota+in+Rosacea:+A+case-control+study.">Characterization and analysis of the skin microbiota in Rosacea: A case-control study.</a> American Journal of Clinical Dermatology. 21 (1), 139-147 (2020).</li><li>Park, S. Y., Kim, H. S., Lee, S. H., Kim, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Characterization+and+analysis+of+the+skin+microbiota+in+acne:+Impact+of+systemic+antibiotics.">Characterization and analysis of the skin microbiota in acne: Impact of systemic antibiotics.</a> Journal of Clinical Medicine. 9 (1), 168 (2020).</li><li>Woo, Y. R., Lee, S. H., Cho, S. H., Lee, J. D., Kim, H. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Characterization+and+analysis+of+the+skin+microbiota+in+Rosacea:+Impact+of+systemic+antibiotics.">Characterization and analysis of the skin microbiota in Rosacea: Impact of systemic antibiotics.</a> Journal of Clinical Medicine. 9 (1), 185 (2020).</li><li>Zheng, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Alterations+in+the+skin+microbiome+are+associated+with+disease+severity+and+treatment+in+the+perioral+zone+of+the+skin+of+infants+with+atopic+dermatitis.">Alterations in the skin microbiome are associated with disease severity and treatment in the perioral zone of the skin of infants with atopic dermatitis.</a> European Journal of Clinical Microbiology &amp; Infectious Diseases. 38 (9), 1677-1685 (2019).</li><li>Tott&#233;, J. E. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Nasal+and+skin+microbiomes+are+associated+with+disease+severity+in+paediatric+atopic+dermatitis.">Nasal and skin microbiomes are associated with disease severity in paediatric atopic dermatitis.</a> The British Journal of Dermatology. 181 (4), 796-804 (2019).</li><li>Zhao, X. Y., Yang, Y. Y., Jl Feng, ., Feng, C. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Network+pharmacology+prediction+and+experimental+validation+of+Trichosanthes-Fritillaria+thunbergii+action+mechanism+against+lung+adenocarcinoma.">Network pharmacology prediction and experimental validation of Trichosanthes-Fritillaria thunbergii action mechanism against lung adenocarcinoma.</a> Journal of Visualized Experiments. (193), e64847 (2023).</li><li>Zeng, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Network+pharmacology+prediction+and+metabolomics+validation+of+the+mechanism+of+Fructus+Phyllanthi+against+hyperlipidemia.">Network pharmacology prediction and metabolomics validation of the mechanism of Fructus Phyllanthi against hyperlipidemia.</a> Journal of Visualized Experiments. (194), e65071 (2023).</li><li>Wang, T., Jiang, X., Ruan, Y., Li, L., Chu, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+mechanism+of+action+of+the+combination+of+Astragalus+membranaceus+and+Ligusticum+chuanxiong+in+the+treatment+of+ischemic+stroke+based+on+network+pharmacology+and+molecular+docking.">The mechanism of action of the combination of Astragalus membranaceus and Ligusticum chuanxiong in the treatment of ischemic stroke based on network pharmacology and molecular docking.</a> Medicine. 101 (28), e29593 (2022).</li><li>Wang, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Exploring+the+mechanism+of+luteolin+by+regulating+microglia+polarization+based+on+network+pharmacology+and+in+vitro+experiments.">Exploring the mechanism of luteolin by regulating microglia polarization based on network pharmacology and in vitro experiments.</a> Scientific Reports. 13 (1), 13767 (2023).</li><li>Qi-Yue, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=From+natural+dye+to+herbal+medicine:+a+systematic+review+of+chemical+constituents,+pharmacological+effects+and+clinical+applications+of+indigo+naturalis.">From natural dye to herbal medicine: a systematic review of chemical constituents, pharmacological effects and clinical applications of indigo naturalis.</a> Chinese Medicine. 15 (1), 127 (2020).</li><li>Andr&#233;, C., Dumur, J. P., Hrabina, M., Lefebvre, E., Sicard, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Juniperus+ashei:+the+gold+standard+of+the+Cuppressaceae.">Juniperus ashei: the gold standard of the Cuppressaceae.</a> Allergie et Immunologie. 32 (3), 104-106 (2000).</li><li>Weidinger, S., Novak, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Atopic+dermatitis.">Atopic dermatitis.</a> Lancet. 387 (10023), 1109-1122 (2016).</li><li>Cai, L. L., Wu, Y., He, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Network+pharmacology+of+Shidu+ointment+in+the+treatment+of+EGFR-TKIs+induced+acneiform+eruptions.">Network pharmacology of Shidu ointment in the treatment of EGFR-TKIs induced acneiform eruptions.</a> China Pharmaceuticals. 29 (16), 5 (2020).</li><li>Gu, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mechanisms+of+indigo+naturalis+on+treating+ulcerative+colitis+explored+by+GEO+gene+chips+combined+with+network+pharmacology+and+molecular+docking.">Mechanisms of indigo naturalis on treating ulcerative colitis explored by GEO gene chips combined with network pharmacology and molecular docking.</a> Scientific Reports. 10 (1), 15204 (2020).</li><li>Lou, Y., Ma, Y., Jin, J., Zhu, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Oral+realgar-indigo+naturalis+formula+plus+retinoic+acid+for+acute+promyelocytic+leukemia.">Oral realgar-indigo naturalis formula plus retinoic acid for acute promyelocytic leukemia.</a> Frontiers in Oncology. 10, 597601 (2021).</li><li>Zhang, Q., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Psoriasis+treatment+using+Indigo+Naturalis:+Progress+and+strategy.">Psoriasis treatment using Indigo Naturalis: Progress and strategy.</a> Journal of Ethnopharmacology. 297, 115522 (2022).</li><li>Naganuma, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Efficacy+of+Indigo+Naturalis+in+a+multicenter+randomized+controlled+trial+of+patients+with+ulcerative+colitis.">Efficacy of Indigo Naturalis in a multicenter randomized controlled trial of patients with ulcerative colitis.</a> Gastroenterology. 154 (4), 935-947 (2018).</li><li>Yang, Q. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Exploring+the+mechanism+of+Indigo+Naturalis+in+the+treatment+of+ulcerative+colitis+based+on+TLR4/MyD88/NF-&#954;B+signaling+pathway+and+gut+microbiota.">Exploring the mechanism of Indigo Naturalis in the treatment of ulcerative colitis based on TLR4/MyD88/NF-&#954;B signaling pathway and gut microbiota.</a> Frontiers in Pharmacology. 12, 674416 (2021).</li><li>Sun, Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Indigo+Naturalis+alleviates+dextran+sulfate+sodium-induced+colitis+in+rats+via+altering+gut+microbiota.">Indigo Naturalis alleviates dextran sulfate sodium-induced colitis in rats via altering gut microbiota.</a> Frontiers in Microbiology. 11, 731 (2020).</li><li>Cao, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Immune+and+metabolic+regulation+mechanism+of+Dangguiliuhuang+decoction+against+insulin+resistance+and+hepatic+steatosis.">Immune and metabolic regulation mechanism of Dangguiliuhuang decoction against insulin resistance and hepatic steatosis.</a> Frontiers in Pharmacology. 8, 445 (2017).</li><li>Min, S. Y., Park, C. H., Yu, H. W., Park, Y. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Anti-inflammatory+and+anti-allergic+effects+of+saponarin+and+its+impact+on+signaling+pathways+of+RAW+264.7,+RBL-2H3,+and+HaCaT+cells.">Anti-inflammatory and anti-allergic effects of saponarin and its impact on signaling pathways of RAW 264.7, RBL-2H3, and HaCaT cells.</a> International Journal of Molecular Sciences. 22 (16), 8431 (2021).</li><li>Seo, K. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Saponarin+from+barley+sprouts+inhibits+NF-&#954;B+and+MAPK+on+LPS-induced+RAW+264.7+cells.">Saponarin from barley sprouts inhibits NF-&#954;B and MAPK on LPS-induced RAW 264.7 cells.</a> Food &amp; Function. 5 (11), 3005-3013 (2014).</li><li>Moreno-Anz&#250;rez, N. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+cytotoxic+and+anti-inflammatory+campesterol+derivative+from+genetically+transformed+hairy+roots+of+Lopezia+racemosa+Cav.+(Onagraceae).">A cytotoxic and anti-inflammatory campesterol derivative from genetically transformed hairy roots of Lopezia racemosa Cav. (Onagraceae).</a> Molecules. 22 (1), 118 (2017).</li><li>Numao, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Tryptanthrin+attenuates+TLR3-mediated+STAT1+activation+in+THP-1+cells.">Tryptanthrin attenuates TLR3-mediated STAT1 activation in THP-1 cells.</a> Immunologic Research. 70 (5), 688-697 (2022).</li><li>Veni, A., Lokeswari, T. S., Pavithra, D., Sugapriya, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Melianone+inhibits+secreted+aspartic+proteases+(SAP),+a+virulence+factor+during+hyphal+formation+in+Candida+albicans.">Melianone inhibits secreted aspartic proteases (SAP), a virulence factor during hyphal formation in Candida albicans.</a> Current Computer-Aided Drug Design. 18 (5), 327-336 (2022).</li><li>Veni, A., Lokeswari, T. S., Krishna Kumari, G. N., Gayathri, D., Sudandiradoss, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Bioactivity+of+melianone+against+Salmonella+and+in+silico+prediction+of+a+membrane+protein+target.">Bioactivity of melianone against Salmonella and in silico prediction of a membrane protein target.</a> 3 Biotech. 10 (10), 460 (2020).</li><li>Ma, M., Lu, H., Yang, Z., Chen, L., Li, Y., Zhang, X. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Differences+in+microbiota+between+acute+and+chronic+perianal+eczema.">Differences in microbiota between acute and chronic perianal eczema.</a> Medicine. 100 (16), e25623 (2021).</li><li>Williams, H. C., Chalmers, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Prevention+of+atopic+dermatitis.">Prevention of atopic dermatitis.</a> Acta Dermato-Venereologica. 100 (12), (2020).</li><li>Nogales, C., Mamdouh, Z. M., List, M., Kiel, C., Casas, A. I., Schmidt, H. H. H. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Network+pharmacology:+curing+causal+mechanisms+instead+of+treating+symptoms.">Network pharmacology: curing causal mechanisms instead of treating symptoms.</a> Trends in Pharmacological Sciences. 43 (2), 136-150 (2022).</li><li>Wang, T., Zhou, Y., Wang, K., Jiang, X., Wang, J., Chen, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Prediction+and+validation+of+potential+molecular+targets+for+the+combination+of+Astragalus+membranaceus+and+Angelica+sinensis+in+the+treatment+of+atherosclerosis+based+on+network+pharmacology.">Prediction and validation of potential molecular targets for the combination of Astragalus membranaceus and Angelica sinensis in the treatment of atherosclerosis based on network pharmacology.</a> Medicine (Baltimore). 101 (26), e29762 (2022).</li><li>Jiang, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Exploration+of+Fuzheng+Yugan+mixture+on+COVID-19+based+on+network+pharmacology+and+molecular+docking.">Exploration of Fuzheng Yugan mixture on COVID-19 based on network pharmacology and molecular docking.</a> Medicine (Baltimore). 102 (3), e32693 (2023).</li><li>Dong, Y., Zhao, Q., Wang, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Network+pharmacology-based+investigation+of+potential+targets+of+astragalus+membranaceous-angelica+sinensis+compound+acting+on+diabetic+nephropathy.">Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy.</a> Scientific Reports. 11 (1), 19496 (2021).</li><li>Wang, T., Jiang, X., Lu, Y., Ruan, Y., Wang, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Identification+and+integration+analysis+of+a+novel+prognostic+signature+associated+with+cuproptosis-related+ferroptosis+genes+and+relevant+lncRNA+regulatory+axis+in+lung+adenocarcinoma.">Identification and integration analysis of a novel prognostic signature associated with cuproptosis-related ferroptosis genes and relevant lncRNA regulatory axis in lung adenocarcinoma.</a> Aging (Albany NY). 15 (5), 1543-1563 (2023).</li><li>Wang, T., Jiang, X., Ruan, Y., Zhuang, J., Yin, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Based+on+network+pharmacology+and+in+vitro+experiments+to+prove+the+effective+inhibition+of+myocardial+fibrosis+by+Buyang+Huanwu+decoction).">Based on network pharmacology and in vitro experiments to prove the effective inhibition of myocardial fibrosis by Buyang Huanwu decoction).</a> Bioengineered. 13 (5), 13767-13783 (2022).</li></ol>

The authors have nothing to disclose.

Atopic dermatitis is a specific form of eczema that shares underlying mechanisms with eczema. Hub genes believed to be related to this condition are TNF, MAPK14, and CASP3. The therapeutic effects of SDG on anal eczema are mainly attributed to its action on the TNF and MAPK signaling pathways via these three hub genes17.
SDG includes five distinct drugs: indigo naturalis, golden cypress, calcined gypsum, calamine, and Chinese Gall. In traditional Chinese medicine, calci...

Anal eczema is an allergic skin condition that affects the perianal region and mucosa, exhibiting various clinical manifestations1. The characteristic symptoms include anal erythema, papules, blisters, erosion, exudates, and crusting. These symptoms mostly arise due to scratching, thickening, and roughness of the affected area2.
Anal eczema, characterized by a prolonged duration of the disease, recurrent attacks, and challenging treatment, can have adverse effects on patients&#39; physical and mental health3. The pathogenesis of anal eczema is not yet clear, and modern medicine suggests that it may be related to local anal lesions, diet, environment, genetics, and other factors4. In addition to avoiding contact with irritants and potential allergens, the treatment of anal eczema mainly focuses on methods such as inhibiting inflammation, anti-allergy, and relieving itching5.
SDG has been extensively utilized for the treatment of anal eczema and other anal conditions. SDG regulates anal skin exudation, reduces moisture, repairs anal skin, and effectively addresses pruritus6,7,8. Furthermore, SDG has the potential to regulate perianus microbiota, thereby improving anus eczema9,10.
Network pharmacology, a novel and interdisciplinary, cutting-edge bioinformatic approach in the realm of artificial intelligence and big data, provides an in-depth exploration of traditional Chinese medicine. This discipline emphasizes the systemic expounding of molecular correlation rules between drugs and diseases from an ecological network perspective. It has been extensively adopted for various aspects, including identifying key active ingredients in herb extracts, deciphering their global mechanisms of action, formulating drug combinations, and studying prescription compatibility. Traditional Chinese prescriptions exhibit the attributes of multi-component and multi-target, signifying their substantial adaptability to the realm of network pharmacology. Driven by this methodology, fresh perspectives have emerged in the examination of complex traditional Chinese medicine systems, furnishing robust technical support for clinical application rationalization and drug innovation11,12,13,14.
This study aims to explore the mechanism of effectiveness of SDG in the treatment of anal eczema. This investigative effort sought to elucidate the mechanism of topical drug administration using a synergistic integration of network pharmacology and GEO datasets. The findings provide valuable insights into the efficacy and underlying mechanisms of SDG in the management of anus eczema, indicating its potential as an effective therapeutic approach for this condition.The detailed workflow diagram of the study is presented in Figure 1.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>AutoDockTools</td>
			<td>AutoDock</td>
			<td>https://autodocksuite.scripps.edu/adt/</td>
			<td></td>
		</tr>
		<tr>
			<td>Cytoscape 3.9.1&#160;</td>
			<td>Cytoscape</td>
			<td>https://cytoscape.org/</td>
			<td></td>
		</tr>
		<tr>
			<td>GeneCards database&#160;</td>
			<td>GeneCards</td>
			<td>https://www.genecards.org</td>
			<td></td>
		</tr>
		<tr>
			<td>GEO database</td>
			<td>National Center for Biotechnology Information</td>
			<td>https://www.ncbi.nlm.nih.gov/geo/</td>
			<td></td>
		</tr>
		<tr>
			<td>GEO2R tool&#160;</td>
			<td>National Center for Biotechnology Information</td>
			<td>https://ncbi.nlm.nih.gov/geo/geo2r/</td>
			<td></td>
		</tr>
		<tr>
			<td>Metascape</td>
			<td>Metascape</td>
			<td>https://metascape.org/</td>
			<td></td>
		</tr>
		<tr>
			<td>Online Mendelian inheritance in man database</td>
			<td>OMIM</td>
			<td>https://www.omim.org</td>
			<td></td>
		</tr>
		<tr>
			<td>RCSB protein database&#160;</td>
			<td>RCSB Protein Data Bank (RCSB PDB)</td>
			<td>http://www.pdb.org/</td>
			<td></td>
		</tr>
		<tr>
			<td>STRING database&#160;</td>
			<td>STRING</td>
			<td>https://string-db.org/</td>
			<td></td>
		</tr>
		<tr>
			<td>Swiss ADME database&#160;</td>
			<td>Swiss Institute of Bioinformatics</td>
			<td>http://www.swissadme.ch/index.php</td>
			<td></td>
		</tr>
		<tr>
			<td>Traditional Chinese Medicine system&#39;s pharmacology database (TCMSP)</td>
			<td>Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform</td>
			<td>http://tcmspw.com/tcmsp.php</td>
			<td></td>
		</tr>
		<tr>
			<td>Venny2.1</td>
			<td>BioinfoGP</td>
			<td>https://bioinfogp.cnb.csic.es/tools/venny/index.html</td>
			<td></td>
		</tr>
	</tbody>
</table>

the efficacy and underlying pathway mechanisms of shidugao treatment for anus eczema based on geo datasets and network pharmacology

Anus eczema is a chronic and recurrent inflammatory skin disease affecting the area around the anus. While the lesions primarily occur in the anal and perianal skin, they can also extend to the perineum or genitalia. ShiDuGao (SDG) has been found to possess significant reparative properties against anal pruritus, exudation control, moisture reduction, and skin repair. However, the genetic targets and pharmacological mechanisms of SDG on anal eczema have yet to be comprehensively elucidated and discussed. Consequently, this study employed a network pharmacological approach and utilized gene expression omnibus (GEO) datasets to investigate gene targets. Additionally, a protein-protein interaction network (PPI) was established, resulting in the identification of 149 targets, of which 59 were deemed hub genes, within the "drug-target-disease" interaction network.
The gene function of SDG in the treatment of perianal eczema was assessed through the utilization of the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analysis. Subsequently, the anti-perianal eczema function and potential pathway of SDG, as identified in network pharmacological analysis, were validated using molecular docking methodology. The biological processes associated with SDG-targeted genes and proteins in the treatment of anus eczema primarily encompass cytokine-mediated responses, inflammatory responses, and responses to lipopolysaccharide, among others. The results of the pathway enrichment and functional annotation analyses suggest that SDG plays a crucial role in preventing and managing anal eczema by regulating the Shigellosis and herpes simplex virus 1 infection pathways. Network pharmacology and GEO database analysis confirms the multi-target nature of SDG in treating anal eczema, specifically by modulating TNF, MAPK14, and CASP3, which are crucial hub targets in the TNF and MAPK signaling pathways. These findings provide a clear direction for further investigation into SDG's therapeutic mechanism for anal eczema while highlighting its potential as an effective treatment approach for this debilitating condition.

Author Spotlight: Exploring ShiDuGao&#039;s Multi-Target Approach in Anus Eczema Treatment

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology

1 This article evaluated the feasibility, target<v>2 and the mechanism of ShiDuGao in treating anus eczema. 3 Network pharmacology and GEO database analysis 4 confirms the multi-target nature of SDG 5 in treating anal eczema, 6 specifically by modulating TNF and APK 14, 7 and the CASP3, 8 which are crucial hub targets in the TNF 9 and MAPK signaling pathways. 10 These fundings provide a clear direction 11 for further investigation into SDG's 12 therapeutic mechanism for anal eczema, 13 while highlighting its potential 14 as an effective treatment approach 15 for this debilitating condition.16 Mechanism research is acknowledged<v>17 as the most intricate aspect 18 of herbal prescription investigation. 19 Network pharmacology currently permits diverse aspect 20 of the pharmacentrical field, 21 making a paradigm shift from conventional 22 to contemporary biomedicine, 23 and refining traditional Chinese medicine development. 24 This research combined network pharmacology 25 with GEO dataset to discern to topical drug mechanisms.26 In this study, the pure data generation method<v>27 was used to maximize data utilization 28 by combining modified disease, 29 especially for some diseases that are difficult 30 to build animal models for. 31 The online data are used primarily to predict 32 and verify diseases and drug targets, 33 so as to gather research direction 34 and lay a good foundation 35 for subsequent experimental verification.

Anus eczema-related genes, SDG target genes, and common targets 
A total of 958 potential gene candidates were screened in Genecards and 634 in OMIM databases, while duplicates were excluded. To gain a comprehensive understanding of anal eczema-related genes, the findings from multiple databases were amalgamated, yielding a total of 958 distinct genes. Consequently, a protein-protein interaction network (PPI) specific to anal eczema was meticulously formulated. SDG is composed of five traditional Ch...

Watch this Scientific Journal Video about The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology at JoVE.com

This investigative effort sought to elucidate the mechanism of topical drug administration using a synergistic integration of network pharmacology and gene expression omnibus (GEO) datasets. This article evaluated the feasibility, target, and mechanism of ShiDuGao (SDG) in treating anus eczema.

Anus eczema is a chronic and recurrent inflammatory skin disease affecting the area around the anus. While the lesions primarily occur in the anal and ...

the-efficacy-underlying-pathway-mechanisms-shidugao-treatment-for

Research

JoVE Journal

Medicine

Identifying Disease Targets and Active Components in Traditional Chinese Medicine for Anus Eczema

Establishing a Drug-Component-Disease-Target Network, GO and KEGG Enrichment, and GEO Gene Chip Dataset Analysis in Anus Eczema

1 To begin, launch the Cytoscape 3.9.1 software<v>2 on the desktop and import the tsv file 3 containing core proteins of anus eczema. 4 Click on the style bar in the control panel 5 to optimize the color, font, and size of the network nodes. 6 For network topology analysis, 7 employ the analyze network function.8 To obtain hub genes, use CytoHubba 9 and establish the drug component disease target network. 10 Open the Metascape website. 11 Select a file or paste a gene list into the dialog box 12 and click the submit button.13 Then select H.sapiens in both input as species 14 and analysis as species, 15 and enable the custom analysis function. 16 In the enrichment option, 17 select GO molecular functions, GO biological processes, 18 GO cellular components, and the KEGG Pathway database. 19 Check pick selective GO clusters, 20 and click on the enrichment analysis button.21 Upon completion of the progress bar, 22 initiate an analysis report page and click 23 to retrieve the enrichment results. 24 Open the GEO2R tool to search 25 and analyze the GEO gene chip database. 26 Open the GEO database website.27 Then enter the keyword or GEO accession 28 and click on the search button. 29 Select the best matching result, 30 and find the reference series. 31 Now on the GEO2R tool website, 32 enter the reference series in the GEO accession box 33 and click the set button.34 Select atopic dermatitis as the experimental group 35 and nonatopic control as the control group. 36 Click the analyze button and wait for the results to appear. 37 KEGG and GO enrichment analyses of 59 key targets 38 identified 218 pathways and over 3, 000 biological processes, 39 highlighting significant pathways in SDG and anal eczema.40 GO analysis on biological processes, cell composition, 41 and molecular function 42 emphasized common targets in SDG and anal eczema. 43 Relevant biological functions included peptidyl-tyrosine 44 phosphorylation and regulation of cell-cell adhesion.

Predicting the Binding of SDG Active Components to Anus Eczema Targets

1 To begin, 2 open the traditional Chinese Medicine Systems 3 Pharmacology database. 4 Using the chemical name search box, 5 search the selected ingredient names 6 to download the corresponding 3D structure files 7 in Mol2 format. 8 To download the crystal structures of the key targets, 9 open the RCSB Protein database.10 In the search box, 11 search the target names 12 and download the corresponding 13 crystal structure files in PDB format. 14 Import ingredients and target structure files 15 in the analysis software. 16 Click Edit, then Delete Water to delete water molecules.17 To add hydrogens, click on Edit, Hydrogens, and Add. 18 Set the ingredients as the ligand. 19 Select whole targets as the receptor 20 and perform blind docking.21 To determine the range of molecular docking, 22 select the receptor and ligand in sequence. 23 Click on Grid, then Grid Box to adjust the grid box 24 to include the entire model. 25 Click on File and Close to save the current grid box status 26 and save the files in GPF format.27 Now click on Run and Run Auto Grid Four, 28 click Parameter File Name, and Browse, 29 to select the GFP file. 30 Then click the Launch button. 31 For molecular docking, 32 open the auto doc four and click on docking, Macromolecule, 33 and set rigid file name to select the receptor.34 Then click on Docking, Ligand and open, 35 or choose to select the ligand. 36 Now click on Docking 37 and Search Parameters to set operation algorithms. 38 Then click Docking and Docking Parameters 39 to set docking parameters.40 Select the DPF file and click the launch button. 41 Save files in the DPF format. 42 Click on Analyze, Docking, 43 and open to select the DLG file.44 Then click on Analyze and Macromolecule 45 to open the receptor. 46 Now click on Analyze, Confirmations, and Play, 47 ranked by energy to analyze the results. 48 Finally, click Set Play, 49 and write complex to save the results in PDBQT format.50 Import the docking files into PyMOLE, 51 then select the ligand and click on Action, Find, 52 Polar Contracts and to other atoms and object 53 to display hydrogen bonds between ligands 54 and the external environment. 55 Click on single letter C to change color. 56 Click Action and Extract Object.57 Click Show, then Sticks, 58 to show the stick structure of the receptor, 59 identify the residuals connected to ligands 60 and show the stick structure. 61 Then click Wizard and Measurement 62 and click on two atoms in sequence. 63 Click Label then Residue to show the label of the residues.64 If necessary, adjust the background color and transparency. 65 Finally, click File, then Export Image As 66 to save the picture. 67 In the atopic dermatitis group, 68 GEO database analysis revealed upregulation 69 of P-P-A-R-G, E-G-F-R, T-N-F 70 and P-T-P-R-C MMP Nine, MAPK 14, 71 and CASP Three were downregulated.72 Docking analysis confirmed the interaction 73 between active SDG components 74 and potential target proteins 75 indicating their significant role in anal eczema treatment. 76 Indigo and Berberrubine demonstrated strong binding activity 77 with energy's less than minus five kilo calories per MOL, 78 emphasizing their therapeutic potential.

532 Views.  Tianjin Medical University General Hospital.  This investigative effort sought to elucidate the mechanism of topical drug administration using a synergistic integration of network pharmacology and gene expression omnibus (GEO) datasets. This article evaluated the feasibility, target, and mechanism of ShiDuGao (SDG) in treating anus eczema. 

Network Pharmacology and GEO Dataset Analysis of SDG in Anus Eczema Treatment

Özet